Page 335 - Read Online

Page 12 of 12 Flynn et al. J Cancer Metastasis Treat 2019;5:43 I http://dx.doi.org/10.20517/2394-4722.2019.13

62. Akalay I, Janji B, Hasmim M, Noman MZ, Andre F et al. Epithelial-to-mesenchymal transition and autophagy induction in breast
carcinoma promote escape from T-cell-mediated lysis. Cancer Res 2013;73:2418-27.
63. Akalay I, Janji B, Hasmim M, Noman MZ, Thiery JP et al. EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis
through autophagy induction. Autophagy 2013;9:1104-6.
64. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007;7:834-46.
65. Chaffer CL, San Juan BP, Lim E, Weinberg RA. EMT, cell plasticity and metastasis. Cancer Metastasis Rev 2016;35:645-54.
66. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012;148:399-408.
67. Whelan KA, Chandramouleeswaran PM, Tanaka K, Natsuizaka M, Guha M, et al. Autophagy supports generation of cells with high
CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance. Oncogene 2017;36:4843-58.
68. Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals.
Cancer Cell 2009;16:67-78.
69. Lee IH, Kawai Y, Fergusson MM, Rovira, II, Bishop AJ, et al. Atg7 modulates p53 activity to regulate cell cycle and survival during
metabolic stress. Science 2012;336:225-8.
70. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis.
Cell 2005;120:237-48.
71. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian
cancer cells. J Clin Invest 2008;118:3917-29.
72. Kimura T, Takabatake Y, Takahashi A, Isaka Y. Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res
2013;73:3-7.
73. Maycotte P, Aryal S, Cummings CT, Thorburn J, Morgan MJ, et al. Chloroquine sensitizes breast cancer cells to chemotherapy
independent of autophagy. Autophagy 2012;8:200-12.
74. Wang H, Yu Y, Jiang Z, Cao WM, Wang Z, et al. Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to
doxorubicin-induced apoptosis. Sci Rep 2016;6:26456.
75. Gavilan E, Giraldez S, Sanchez-Aguayo I, Romero F, Ruano D, et al. Breast cancer cell line MCF7 escapes from G1/S arrest induced by
proteasome inhibition through a GSK-3beta dependent mechanism. Sci Rep 2015;5:10027.
76. Milani M, Rzymski T, Mellor HR, Pike L, Bottini A, et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer
cells treated with Bortezomib. Cancer Res 2009;69:4415-23.
77. Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, et al. Mitochondrial membrane permeabilization is a critical step of
lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 2003;22:3927-36.
78. Choi DS, Blanco E, Kim YS, Rodriguez AA, Zhao H, et al. Chloroquine eliminates cancer stem cells through deregulation of Jak2 and
DNMT1. Stem Cells 2014;32:2309-23.
79. Royce ME, Osman D. Everolimus in the Treatment of Metastatic Breast Cancer. Breast Cancer (Auckl) 2015;9:73-9.
80. Vinayak S, Carlson RW. mTOR inhibitors in the treatment of breast cancer. Oncology (Williston Park) 2013;27:38-44, 6, 8 passim.
81. Ellard SL, Clemons M, Gelmon KA, Norris B, Kennecke H, et al. Randomized phase II study comparing two schedules of everolimus in
patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163. J Clin Oncol 2009;27:4536-41.
82. Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, et al. Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast
Cancer Res Treat 2012;136:355-63.
83. Liu Y, Shoji-Kawata S, Sumpter RM, Jr., Wei Y, Ginet V, et al. Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by
autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci U S A 2013;110:20364-71.
84. Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, et al. The autophagic tumor stroma model of cancer: Role of
oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 2010;9:3485-505.
85. Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, et al. Autophagy in cancer associated fibroblasts
promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell
Cycle 2010;9:3515-33.
86. Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell RG, Pavlides S, et al. Caveolin-1 and cancer metabolism in the tumor
microenvironment: markers, models, and mechanisms. Annu Rev Pathol 2012;7:423-67.